Proteomic markers with prognostic impact on outcome of chronic lymphocytic leukemia patients under chemo-immunotherapy: results from the HOVON 109 studyFatemeh Saberi Hosnijeh, Mark‐David Levin, Jeanette K. Doorduijn et al.|Experimental Hematology|2020Cited by 8